Dysfibrinogen Kagoshima with the amino acid substitution γThr-314 to Ile: Analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule

Thrombosis Research

Volumn 121, Issue 6, 2008, Pages 773-780

  Niwa, Kazuki ^a,b   Mimuro, Jun ^a   Miyata, Masaaki ^c   Sugo, Teruko ^a   Ohmori, Tsukasa ^a   Madoiwa, Seiji ^a   Tei, Chuwa ^c   Sakata, Yoichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

chain; Dysfibrinogen; Fibrinogen; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 8; CALCIUM ION; FIBRINOGEN; ISOLEUCINE; MONOMER; THREONINE; THROMBIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; BLOOD CLOTTING; CALCIUM BINDING; CASE REPORT; CROSS LINKING; DEEP VEIN THROMBOSIS; DYSFIBRINOGEN KAGOSHIMA; DYSFIBRINOGENEMIA; FEMALE; FIBRIN POLYMERIZATION; HUMAN; HYPOFIBRINOGENEMIA; MOLECULAR GENETICS; PRIORITY JOURNAL; PUERPERIUM; SCANNING ELECTRON MICROSCOPY; THROMBOPHILIA;

ADULT; AMINO ACID SUBSTITUTION; CALCIUM; CATALYSIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FIBRIN; FIBRINOGEN; FIBRINOGENS, ABNORMAL; HUMANS; IONS; MICROSCOPY, ELECTRON, SCANNING; PLASMIN; POLYMERASE CHAIN REACTION; POSTPARTUM PERIOD; SOLUBILITY; SURFACE PROPERTIES; THROMBIN; THROMBOPHILIA; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; VENOUS THROMBOSIS;

EID: 41749088498     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.07.007     Document Type: Article

References (18)

1. Mosesson M.W. Fibrinogen and fibrin structure and functions. J Thromb Haemost 3 8 (2005) 1894-1904
2. Weisel J.W. Fibrinogen and fibrin. Adv Protein Chem 70 (2005) 247-299
3. Huang S., Mulvihill E.R., Farrell D.H., Chung D.W., and Davie E.W. Biosynthesis of human fibrinogen: subunit interactions and potential intermediates in the assembly. J Biol Chem 268 12 (1993) 8919-8926
4. Matsuda M. Structure and function of fibrinogen inferred from hereditary dysfibrinogens. Int J Hematol 72 4 (2000) 436-447
5. Haverkate F., and Samama M. Familial dysfibrinogenemia and thrombophilia. Thromb Haemost 73 1 (1995) 151-161
6. Brennan S.O., Fellowes A.P., and George P.M. Molecular mechanisms of hypo- and afibrinogenemia. Ann N Y Acad Sci 936 (2001) 91-100
7. Keller M.A., Martinez J., Baradet T.C., Nagaswami C., Chernysh I.N., Borowski M.K., et al. Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to γ S378P mutation. Blood 105 8 (2005) 3162-3168
8. Cote H.C., Lord S.T., and Pratt K.P. γ-chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the chain γ of human fibrinogen. Blood 92 7 (1998) 2195-2212
9. Koopman J., Haverkate F., Lord S.T., Grimbergen J., and Mannucci P.M. Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of Bβ 68 Ala→Thr. J Clin Invest 90 1 (1992) 238-244
10. Koopman J., Haverkate F., Grimbergen J., Lord S.T., Mosesson M.W., DiOrio J.P., et al. Molecular basis for fibrinogen Dusart (A alpha 554 Arg→Cys) and its association with abnormal fibrin polymerization and thrombophilia. J Clin Invest 91 4 (1993) 1637-1643
11. Marchi R., Lundberg U., Grimbergen J., Koopman J., Torres A., de Bosch N.B., et al. Fibrinogen Caracas V, an abnormal fibrinogen with an Aα 532 Ser→Cys substitution associated with thrombosis. Thromb Haemost 84 2 (2000) 263-270
12. Hamano A., Mimuro J., Aoshima M., Itoh T., Kitamura N., Nishinarita S., et al. Thrombophilic Dysfibrinogen Tokyo V with the amino acid substitution of γ Ala-327 to Thr: formation of fragile but fibrinolysis-resistant fibrin clots and its relevance to arterial thromboembolism. Blood 103 8 (2004) 3045-3050
13. Castaman G., Ghiotto R., Tosetto A., and Rodeghiero F. Bβ 14 Arg→Cys variant dysfibrinogen and its association with thrombosis. J Thromb Haemost 3 2 (2005) 409-410
14. Mimuro J., Kawata Y., Niwa K., Muramatsu S., Madoiwa S., Takano H., et al. A new type of Ser substitution for γArg-275 in fibrinogen Kamogawa I characterized by impaired fibrin assembly. Thromb Haemost 81 6 (1999) 940-944
15. Mimuro J., Hamano A., Tanaka T., Madoiwa S., Sugo T., Matsuda M., et al. Hypofibrinogenemia caused by a nonsense mutation in the fibrinogen Bβ chain gene. J Thromb Haemost 1 11 (2003) 2356-2359
16. Wilhelm S.E., Lounes K.C.C., and Lord S.T. Investigation of residues in the fibrin(ogen) γ chain involved in tissue plasminogen activator binding an plasminogen activation. Blood Coagul Fibrinolysis 15 6 (2004) 451-461
17. Sugo T., Nakamikawa C., Takano H., Mimuro J., Yamaguchi S., Mosesson MW., et al. Fibrinogen Niigata with impaired fibrin assembly: an inherited dysfibrinogen with a Bβ Asn-160 to Ser substitution associated with extra glycosylation at Bβ Asn-158. Blood 94 11 (1999) 3806-3813
18. Spraggon G., Everse S.J., and Doolittle R.F. Crystal structure of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 389 6650 (1997) 455-462